Lanthionine synthetase component C-like protein 2: A new drug target for inflammatory diseases and diabetes

Current Drug Targets

Volumn 15, Issue 6, 2014, Pages 565-572

  Lu, Pinyi ^a   Hontecillas, Raquel ^a   Philipson, Casandra W ^a   Bassaganya Riera, Josep ^a,b  

^a VIRGINIA BIOINFORMATICS INSTITUTE   (United States)

^b VIRGINIA MARYLAND REGIONAL COLLEGE OF VETERINARY MEDICINE   (United States)

Author keywords

ABA; Drug discovery; Inflammation; LANCL2; Molecular modeling; Target

Indexed keywords

ABSCISIC ACID; ANTIDIABETIC AGENT; ANTIINFLAMMATORY AGENT; CYCLIC AMP; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LANTHIONINE; LANTHIONINE SYNTHETASE C LIKE PROTEIN 1; LANTHIONINE SYNTHETASE C LIKE PROTEIN 2; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; UNCLASSIFIED DRUG; LANCL2 PROTEIN, HUMAN; MEMBRANE PROTEIN; NUCLEAR PROTEIN;

ANTIINFLAMMATORY ACTIVITY; DIABETES MELLITUS; HUMAN; IMMUNE SYSTEM; IMMUNOPATHOLOGY; INFLAMMATION; INFLAMMATORY DISEASE; LYMPH NODE; MACROPHAGE; MOLECULAR DOCKING; MYRISTYLATION; NONHUMAN; NUCLEOTIDE SEQUENCE; PANCREAS ISLET BETA CELL; PROTEIN EXPRESSION; PROTEIN SECONDARY STRUCTURE; REVIEW; SURFACE PLASMON RESONANCE; ANIMAL; ANTAGONISTS AND INHIBITORS; CHEMICAL STRUCTURE; CHEMISTRY; GENETICS; METABOLISM; MOUSE; PROTEIN CONFORMATION;

ABSCISIC ACID; ANIMALS; ANTI-INFLAMMATORY AGENTS; HUMANS; HYPOGLYCEMIC AGENTS; INFLAMMATION; MEMBRANE PROTEINS; MICE; MODELS, MOLECULAR; NUCLEAR PROTEINS; PROTEIN CONFORMATION;

EID: 84899843449     PISSN: 13894501     EISSN: 18735592     Source Type: Journal    
DOI: 10.2174/1389450115666140313123714     Document Type: Review

References (43)

1. Bauer H, Mayer H, Marchler-Bauer A, Salzer U, Prohaska R. Characterization of p40/GPR69A as a peripheral membrane protein related to the lantibiotic synthetase component C. Biochem Biophys Res Commun 2000; 275(1): 69-74.
2. Chatterjee C, Paul M, Xie L, van der Donk WA. Biosynthesis and mode of action of lantibiotics. Chem Rev 2005; 105(2): 633-84.
3. Chen JG, Ellis BE. GCR2 is a new member of the eukaryotic lanthionine synthetase component C-like protein family. Plant Signal Behav 2008; 3(5): 307-10.
4. Mayer H, Breuss J, Ziegler S, Prohaska R. Molecular characterization and tissue-specific expression of a murine putative G-protein-coupled receptor. Biochim Biophys Acta 1998; 1399(1): 51-6.
5. Mayer H, Pongratz M, Prohaska R. Molecular cloning, characterization, and tissue-specific expression of human LANCL2, a novel member of the LanC-like protein family. DNA Seq 2001; 12(3): 161-6.
6. Park S, James CD. Lanthionine synthetase components C-like 2 increases cellular sensitivity to adriamycin by decreasing the expression of P-glycoprotein through a transcription-mediated mechanism. Cancer Res 2003; 63(3): 723-7.
7. Landlinger C, Salzer U, Prohaska R. Myristoylation of human LanC-like protein 2 (LANCL2) is essential for the interaction with the plasma membrane and the increase in cellular sensitivity to adriamycin. Biochim Biophys Acta 2006; 1758(11): 1759-67.
8. Sturla L, Fresia C, Guida L, et al. LANCL2 is necessary for abscisic acid binding and signaling in human granulocytes and in rat insulinoma cells. J Biol Chem 2009; 284(41): 28045-57.
9. Bassaganya-Riera J, Skoneczka J, Kingston DG, et al. Mechanisms of action and medicinal applications of abscisic Acid. Curr Med Chem 2010; 17(5): 467-78.
10. Bruzzone S, Moreschi I, Usai C, et al. Abscisic acid is an endogenous cytokine in human granulocytes with cyclic ADPribose as second messenger. Proc Natl Acad Sci USA 2007; 104(14): 5759-64.
11. Guri AJ, Hontecillas R, Si H, Liu D, Bassaganya-Riera J. Dietary abscisic acid ameliorates glucose tolerance and obesity-related inflammation in db/db mice fed high-fat diets. Clin Nutr 2007; 26(1): 107-16.
12. Guri AJ, Hontecillas R, Ferrer G, et al. Loss of PPAR gamma in immune cells impairs the ability of abscisic acid to improve insulin sensitivity by suppressing monocyte chemoattractant protein-1 expression and macrophage infiltration into white adipose tissue. J Nutr Biochem 2008; 19(4): 216-28.
13. Bassaganya-Riera J, Guri AJ, Lu P, et al. Abscisic acid regulates inflammation via ligand-binding domain-independent activation of peroxisome proliferator-activated receptor gamma. J Biol Chem 2011; 286(4): 2504-16.
14. Lu P, Bevan DR, Lewis SN, Hontecillas R, Bassaganya-Riera J. Molecular modeling of lanthionine synthetase component C-like protein 2: a potential target for the discovery of novel type 2 diabetes prophylactics and therapeutics. J Mol Model 2011; 17(3): 543-53.
15. Sturla L, Fresia C, Guida L, et al. Binding of abscisic acid to human LANCL2. Biochem Biophys Res Commun 2011; 415(2): 390-5.
16. Lu P, Hontecillas R, Horne WT, et al. Computational modelingbased discovery of novel classes of anti-inflammatory drugs that target lanthionine synthetase C-like protein 2. PLoS One 2012; 7(4): e34643.
17. Walker JE, Saraste M, Runswick MJ, Gay NJ. Distantly related sequences in the alpha-and beta-subunits of ATP synthase, myosin, kinases and other ATP-requiring enzymes and a common nucleotide binding fold. EMBO J 1982; 1(8): 945-51.
18. Doering TA, Crawford A, Angelosanto JM, Paley MA, Ziegler CG, Wherry EJ. Network analysis reveals centrally connected genes and pathways involved in CD8+ T cell exhaustion versus memory. Immunity 2012; 37(6): 1130-44.
19. Zhang W, Wang L, Liu Y, et al. Structure of human lanthionine synthetase C-like protein 1 and its interaction with Eps8 and glutathione. Genes Dev 2009; 23(12): 1387-92.
20. Melo F, Feytmans E. Assessing protein structures with a non-local atomic interaction energy. J Mol Biol 1998; 277(5): 1141-52.
21. Rost B. Twilight zone of protein sequence alignments. Protein Eng 1999; 12(2): 85-94.
22. Keren I, Klipcan L, Bezawork-Geleta A, Kolton M, Shaya F, Ostersetzer-Biran O. Characterization of the molecular basis of group II intron RNA recognition by CRS1-CRM domains. J Biol Chem 2008; 283(34): 23333-42.
23. Zhao R, Shin DS, Fiser A, Goldman ID. Identification of a functionally critical GXXG motif and its relationship to the folate binding site of the proton-coupled folate transporter (PCFTSLC46A1). Am J Physiol Cell Physiol 2012; 303(6): C673-81.
24. Arnold K, Bordoli L, Kopp J, Schwede T. The SWISS-MODEL workspace: a web-based environment for protein structure homology modelling. Bioinformatics 2006; 22(2): 195-201.
25. Nambara E, Marion-Poll A. Abscisic acid biosynthesis and catabolism. Annu Rev Plant Biol 2005; 56: 165-85.
26. Bruzzone S, Bodrato N, Usai C, et al. Abscisic Acid Is an Endogenous Stimulator of Insulin Release from Human Pancreatic Islets with Cyclic ADP Ribose as Second Messenger. J Biol Chem 2008; 283(47): 32188-97.
27. Magnone M, Bruzzone S, Guida L, et al. Abscisic acid released by human monocytes activates monocytes and vascular smooth muscle cell responses involved in atherogenesis. J Biol Chem 2009; 284(26): 17808-18.
28. Utsumi T, Ohta H, Kayano Y, Sakurai N, Ozoe Y. The N-terminus of B96Bom, a Bombyx mori G-protein-coupled receptor, is Nmyristoylated and translocated across the membrane. FEBS J 2005; 272(2): 472-81.
29. Zhou J, Liu M, Aneja R, Chandra R, Lage H, Joshi HC. Reversal of P-glycoprotein-mediated multidrug resistance in cancer cells by the c-Jun NH2-terminal kinase. Cancer Res 2006; 66(1): 445-52.
30. Guri AJ, Hontecillas R, Bassaganya-Riera J. Abscisic acid ameliorates experimental IBD by downregulating cellular adhesion molecule expression and suppressing immune cell infiltration. Clin Nutr 2010; 29(6): 824-31.
31. Guri AJ, Hontecillas R, Bassaganya-Riera J. Abscisic acid synergizes with rosiglitazone to improve glucose tolerance and down-modulate macrophage accumulation in adipose tissue: possible action of the cAMP/PKA/PPAR gamma axis. Clin Nutr 2010; 29(5): 646-53.
32. Guri AJ, Misyak SA, Hontecillas R, et al. Abscisic acid ameliorates atherosclerosis by suppressing macrophage and CD4+ T cell recruitment into the aortic wall. J Nutr Biochem 2010; 21(12): 1178-85.
33. Lazennec G, Canaple L, Saugy D, Wahli W. Activation of peroxisome proliferator-activated receptors (PPARs) by their ligands and protein kinase A activators. Mol Endocrinol 2000; 14(12): 1962-75.
34. Avni D, Ernst O, Philosoph A, Zor T. Role of CREB in modulation of TNFalpha and IL-10 expression in LPS-stimulated RAW264.7 macrophages. Molecular immunology 2010; 47(7-8): 1396-403.
35. Bourtchuladze R, Frenguelli B, Blendy J, Cioffi D, Schutz G, Silva AJ. Deficient long-term memory in mice with a targeted mutation of the cAMP-responsive element-binding protein. Cell 1994; 79(1): 59-68.
36. Bruzzone S, Basile G, Mannino E, et al. Autocrine abscisic acid mediates the UV-B-induced inflammatory response in human granulocytes and keratinocytes. J Cell Physiol 2012; 227(6): 2502-10.
37. Magnone M, Sturla L, Jacchetti E, et al. Autocrine abscisic acid plays a key role in quartz-induced macrophage activation. FASEB J 2012; 26(3): 1261-71.
38. Shoichet BK. Virtual screening of chemical libraries. Nature 2004; 432(7019): 862-5.
39. Irwin JJ, Shoichet BK. ZINC--a free database of commercially available compounds for virtual screening. J Chem Inf Model 2005; 45(1): 177-82.
40. Chung CH, Kurien BT, Mehta P, et al. Identification of lanthionine synthase C-like protein-1 as a prominent glutathione binding protein expressed in the mammalian central nervous system. Biochemistry 2007; 46(11): 3262-9.
41. Hensley K, Venkova K, Christov A. Emerging biological importance of central nervous system lanthionines. Molecules 2010; 15(8): 5581-94.
42. Zhong WX, Wang YB, Peng L, et al. Lanthionine synthetase C-like protein 1 interacts with and inhibits cystathionine beta-synthase: a target for neuronal antioxidant defense. J Biol Chem 2012; 287(41): 34189-201.
43. Hruz T, Laule O, Szabo G, et al. Genevestigator v3: a reference expression database for the meta-analysis of transcriptomes. Adv Bioinformatics 2008; 2008: 420747.